Based on the findings in this study, we propose that the significantly reduced expression of both SOX7 and AXIN2 may jointly facilitate the pathogenesis of breast cancer, possibly through regulating the β-catenin by not-direct as well as direct ways. This evidence concerns the gene AXIN2 and breast carcinoma.